← back to search

Joseph A. Lewnard

University of California, Berkeley · US
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Pneumonia and Respiratory Infections, Respiratory viral infections research, SARS-CoV-2 and COVID-19 Research, and COVID-19 epidemiological studies.
h-index
36
citations
6,115
works
156
NIH funding
primary concept
Medicine
email

Recent publications

Extensive cryptic circulation sustains mpox among men who have sex with men.
2026cited by 0position: contributordoi
Pneumococcal Serotype Distribution and Coverage of Existing and Pipeline Pneumococcal Vaccines
The Journal of Infectious Diseases 2025cited by 7position: lastdoi
Strength and durability of indirect protection against SARS-CoV-2 infection through vaccine and infection-acquired immunity.
2025cited by 7position: contributordoi
Bacterial sexually transmitted infections and related antibiotic use among individuals eligible for doxycycline post-exposure prophylaxis in the United States
Nature Communications 2025cited by 5position: middledoi
Pediatric Antibiotic Use Associated With Respiratory Syncytial Virus and Influenza in the United States, 2008–2018
The Journal of Infectious Diseases 2025cited by 3position: lastdoi
Bacterial sexually transmitted infections and related antibiotic use among individuals eligible for doxycycline post-exposure prophylaxis in the United States.
2025cited by 2position: contributordoi
Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineage.
2024cited by 25position: contributordoi
Upper respiratory <i>Streptococcus pneumoniae</i> colonization among working-age adults with prevalent exposure to overcrowding.
2024cited by 3position: contributordoi
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
Nature Medicine 2023cited by 233position: middledoi
Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome.
2023cited by 31position: contributordoi
Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city.
2023cited by 21position: contributordoi
Increased vaccine sensitivity of an emerging SARS-CoV-2 variant.
2023cited by 12position: contributordoi
Burden of Lower Respiratory Tract Infections Preventable by Adult Immunization With 15- and 20-Valent Pneumococcal Conjugate Vaccines in the United States
Clinical Infectious Diseases 2023cited by 9position: firstdoi
Effectiveness of Pneumococcal Conjugate Vaccination Against Virus-Associated Lower Respiratory Tract Infection Among Adults: A Case-Control Study
The Journal of Infectious Diseases 2022cited by 27position: firstdoi
Impact of COVID-19 Pandemic on California Farmworkers' Mental Health and Food Security.
2022cited by 17position: contributordoi
Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines
Epidemiology 2021cited by 120position: firstdoi
Prevention of Coronavirus Disease 2019 (COVID-19) by mRNA-Based Vaccines Within the General Population of California
Clinical Infectious Diseases 2021cited by 61position: middledoi
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Medically Attended Lower Respiratory Tract Infection and Pneumonia Among Older Adults
Clinical Infectious Diseases 2021cited by 52position: firstdoi
Prevalence and Clinical Profile of Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Farmworkers, California, USA, June–November 2020
Emerging infectious diseases 2021cited by 33position: firstdoi
Scientific and ethical basis for social-distancing interventions against COVID-19
The Lancet Infectious Diseases 2020cited by 1,002position: firstdoi
Epidemiology and transmission dynamics of COVID-19 in two Indian states
Science 2020cited by 513position: lastdoi
Epidemiology and transmission dynamics of COVID-19 in two Indian states.
2020cited by 346position: contributordoi
Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study
BMJ 2020cited by 224position: firstdoi
Caution Warranted: Using the Institute for Health Metrics and Evaluation Model for Predicting the Course of the COVID-19 Pandemic
Annals of Internal Medicine 2020cited by 161position: middledoi
Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study.
2020cited by 159position: contributordoi
Combining genomics and epidemiology to track mumps virus transmission in the United States
PLoS Biology 2020cited by 63position: middledoi
The Use of Test-negative Controls to Monitor Vaccine Effectiveness
Epidemiology 2019cited by 182position: middledoi
Evaluating strategies to improve rotavirus vaccine impact during the second year of life in Malawi
Science Translational Medicine 2019cited by 37position: middledoi
Evaluating strategies to improve rotavirus vaccine impact during the second year of life in Malawi.
2019cited by 34position: contributordoi
Heterogeneous susceptibility to rotavirus infection and gastroenteritis in two birth cohort studies: Parameter estimation and epidemiological implications.
2019cited by 9position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 10 papers (2019–2026)Sara Y. Tartof · University of Colorado Denver8 papers (2021–2026)Nicholas P. Jewell · London School of Hygiene & Tropical Medicine5 papers (2020–2022)Katia Bruxvoort · University of Alabama at Birmingham5 papers (2021–2025)Benjamin A. Lopman · Emory University5 papers (2017–2021)Naor Bar‐Zeev · World Health Organization4 papers (2017–2019)Virginia E. Pitzer · University of Antwerp4 papers (2017–2019) · 4 papers (2023–2026)Marc Lipsitch · Center for Disease Dynamics, Economics & Policy3 papers (2019–2024)Vennis Hong · Kaiser Permanente3 papers (2021–2023)Laura King · University of California, Berkeley3 papers (2025–2025)Bradford D. Gessner · University of London3 papers (2021–2023)Luis Jódar · Pfizer (United States)3 papers (2021–2023) · 3 papers (2021–2023)Nathan C. Lo · The University of Sydney3 papers (2020–2025) · 3 papers (2021–2023)Umesh D. Parashar · Centers for Disease Control and Prevention2 papers (2017–2019)Miwako Kobayashi · Centers for Disease Control and Prevention2 papers (2021–2025)Benjamin J. Cowling · Laboratory of Data Discovery for Health2 papers (2019–2021)Kristin L. Andrejko · London School of Hygiene & Tropical Medicine2 papers (2021–2025)